114 related articles for article (PubMed ID: 2117290)
21. 1,4-Dihydronaphthoquinones, hydroindoloquinones, benzofurans, and benzothiophenes as inhibitors of 5-lipoxygenase. Synthesis and structure-activity studies.
Yamashita A; Schaub RG; Bach MK; White GJ; Toy A; Ghazal NB; Burdick MD; Brashler JR; Holm MS
J Med Chem; 1990 Feb; 33(2):775-81. PubMed ID: 2153828
[TBL] [Abstract][Full Text] [Related]
22. Effect of lipoxygenase inhibitors, AA-861 and T-22083, on chemical mediators released from sensitized guinea-pig lung tissue.
Ishihara Y; Kitamura S; Takaku F
Prostaglandins; 1983 Oct; 26(4):623-9. PubMed ID: 6419291
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of release of beta-endorphin from rat pituitary cells. Role of lipoxygenase products of arachidonic acid.
Nishizaki T; Ikegami H; Tasaka K; Hirota K; Miyake A; Tanizawa O
Neuroendocrinology; 1989 May; 49(5):483-8. PubMed ID: 2524676
[TBL] [Abstract][Full Text] [Related]
24. Endogenous lipoxygenase metabolites mediate A23187 induced macrophage cytostasis towards P815 tumor cells in vitro.
van Hilten JA; Elliott GR; Bonta IL
Agents Actions; 1989 Jan; 26(1-2):170-2. PubMed ID: 2496588
[TBL] [Abstract][Full Text] [Related]
25. Effect of 5-lipoxygenase inhibitor on experimental delayed cerebral vasospasm.
Yokota M; Tani E; Maeda Y; Kokubu K
Stroke; 1987; 18(2):512-8. PubMed ID: 3564111
[TBL] [Abstract][Full Text] [Related]
26. 5-lipoxygenase inhibitor (AA-861) attenuates neutrophil-mediated oxidative stress on the venular endothelium in endotoxemia.
Suematsu M; Miura S; Suzuki M; Nagata H; Morishita T; Oshio C; Tsuchiya M
J Clin Lab Immunol; 1988 Jan; 25(1):41-5. PubMed ID: 3385768
[TBL] [Abstract][Full Text] [Related]
27. Effect of AA-861, a 5-lipoxygenase inhibitor, on leukotriene synthesis in human polymorphonuclear leukocytes and on cyclooxygenase and 12-lipoxygenase activities in human platelets.
Mita H; Yui Y; Shida T
Allergy; 1986 Sep; 41(7):493-8. PubMed ID: 3024521
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the 5-lipoxygenase pathway with piriprost (U-60,257) protects normal primates from ozone-induced methacholine hyperresponsive small airways.
Johnson HG; Stout BK; Ruppel PL
Prostaglandins; 1988 Mar; 35(3):459-66. PubMed ID: 3287458
[TBL] [Abstract][Full Text] [Related]
29. Examination of the effects of piriprost (U-60,257B) on alkaline phosphatase activity of rat endometrial stromal cells in vitro.
Cejic SS; Kennedy TG
Prostaglandins; 1991 Aug; 42(2):179-89. PubMed ID: 1775638
[TBL] [Abstract][Full Text] [Related]
30. Antiproliferative effects of lipoxygenase inhibitors on malignant human hematopoietic cell lines.
Snyder DS; Castro R; Desforges JF
Exp Hematol; 1989 Jan; 17(1):6-9. PubMed ID: 2908862
[TBL] [Abstract][Full Text] [Related]
31. Involvement of 5-lipoxygenase metabolites in ACTH-stimulated corticosteroidogenesis in rat adrenal glands.
Hirai A; Tahara K; Tamura Y; Saito H; Terano T; Yoshida S
Prostaglandins; 1985 Nov; 30(5):749-67. PubMed ID: 3001830
[TBL] [Abstract][Full Text] [Related]
32. Effect of AA861, a 5-lipoxygenase inhibitor, on amylase secretion from rat pancreatic acini.
Sato S; Adachi H; Noguchi M; Honda T; Onishi S; Aoki E; Torizuka K
Biochim Biophys Acta; 1988 Jan; 968(1):1-8. PubMed ID: 2447953
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the leukotriene synthetase of rat basophil leukemia cells by diethylcarbamazine, and synergism between diethylcarbamazine and piriprost, a 5-lipoxygenase inhibitor.
Bach MK; Brashler JR
Biochem Pharmacol; 1986 Feb; 35(3):425-33. PubMed ID: 3004501
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological profile of AA-861, a 5-lipoxygenase inhibitor.
Ashida Y; Saijo T; Kuriki H; Makino H; Terao S; Maki Y
Prostaglandins; 1983 Dec; 26(6):955-72. PubMed ID: 6084855
[TBL] [Abstract][Full Text] [Related]
35. Lipoxygenase pathway in islet endocrine cells. Oxidative metabolism of arachidonic acid promotes insulin release.
Metz S; VanRollins M; Strife R; Fujimoto W; Robertson RP
J Clin Invest; 1983 May; 71(5):1191-205. PubMed ID: 6406544
[TBL] [Abstract][Full Text] [Related]
36. Novel 1H-benzimidazol-4-ols with potent 5-lipoxygenase inhibitory activity.
Buckle DR; Foster KA; Taylor JF; Tedder JM; Thody VE; Webster RA; Bermudez J; Markwell RE; Smith SA
J Med Chem; 1987 Dec; 30(12):2216-21. PubMed ID: 3681891
[TBL] [Abstract][Full Text] [Related]
37. Effects of a 5-lipoxygenase inhibitor, AA861, on lipoxygenase metabolism and superoxide anion generation by human polymorphonuclear leukocytes--potentiation of superoxide anion generation by LTB4.
Tanaka K; Abe M; Shigematsu N
Int Arch Allergy Immunol; 1992; 98(4):361-9. PubMed ID: 1330136
[TBL] [Abstract][Full Text] [Related]
38. The inhibitory effect of suramin on telomerase activity and spheroid growth of C6 glioma cells.
Erguven M; Akev N; Ozdemir A; Karabulut E; Bilir A
Med Sci Monit; 2008 Aug; 14(8):BR165-73. PubMed ID: 18667993
[TBL] [Abstract][Full Text] [Related]
39. Experiments on the mode of action of piriprost (U-60,257), an inhibitor of leukotriene formation in cloned mouse mast cells and in rat basophil leukemia cells.
Bach MK; Brashler JR; White GJ; Galli SJ
Biochem Pharmacol; 1987 May; 36(9):1461-6. PubMed ID: 3107573
[TBL] [Abstract][Full Text] [Related]
40. A possible requirement for arachidonic acid lipoxygenation in the mechanism of phagocytic degranulation by human neutrophils stimulated with aggregated immunoglobulin G.
Smith RJ; Yein FS; Speziale SC; Bowman BJ
Biochem Biophys Res Commun; 1986 Apr; 136(1):310-5. PubMed ID: 3010968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
